Literature DB >> 9880043

Human apolipoprotein E allele-specific brain expressing transgenic mice.

J D Smith1, J Sikes, J A Levin.   

Abstract

Transgenic mice were created using human apolipoprotein E2, E3, and E4 gene fragments driven by the human glial acidic fibrillary protein (GFAP) promoter. Founders were obtained and progeny were assayed for transgene expression in the brain by RNase protection, immunohistochemistry, and Western blotting, demonstrating robust apolipoprotein E (apoE) brain expression, with human apoE representing up to approximately 0.2% of total brain protein. Selected lines were bred to apoE-deficient mice yielding mice which expressed the human transgenic apoE isoforms in the absence of endogenous apoE. Immunohistochemistry revealed accumulation of the transgene encoded human apoE throughout the brain. Double immunofluorescence showed co-expression of the apoE transgene with endogenous glial acidic fibrillary protein. Primary astrocyte cultures from the transgenic mice secreted human apoE into the medium. Aged apoE4 transgenic mouse brain failed to demonstrate any evidence of senile plaques. These mice may be useful for elucidation of the mechanism by which apoE4 is associated with Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9880043     DOI: 10.1016/s0197-4580(98)00076-1

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  10 in total

1.  Exercise improves cognition and hippocampal plasticity in APOE epsilon4 mice.

Authors:  Kathryn Nichol; Sean P Deeny; Joseph Seif; Kevin Camaclang; Carl W Cotman
Journal:  Alzheimers Dement       Date:  2009-07       Impact factor: 21.566

2.  Cellular source of apolipoprotein E4 determines neuronal susceptibility to excitotoxic injury in transgenic mice.

Authors:  Manuel Buttini; Eliezer Masliah; Gui-Qiu Yu; Jorge J Palop; Shengjun Chang; Aubrey Bernardo; Carol Lin; Tony Wyss-Coray; Yadong Huang; Lennart Mucke
Journal:  Am J Pathol       Date:  2010-07-01       Impact factor: 4.307

Review 3.  Doxycycline-inducible and astrocyte-specific HIV-1 Tat transgenic mice (iTat) as an HIV/neuroAIDS model.

Authors:  Dianne Langford; Byung Oh Kim; Wei Zou; Yan Fan; Pejman Rahimain; Ying Liu; Johnny J He
Journal:  J Neurovirol       Date:  2017-11-15       Impact factor: 2.643

4.  Abeta42 neurotoxicity in primary co-cultures: effect of apoE isoform and Abeta conformation.

Authors:  Arlene M Manelli; Lindsey C Bulfinch; Patrick M Sullivan; Mary Jo LaDu
Journal:  Neurobiol Aging       Date:  2006-07-11       Impact factor: 4.673

5.  Robust in vivo transduction of nervous system and neural stem cells by early gestational intra amniotic gene transfer using lentiviral vector.

Authors:  David H Stitelman; Masayuki Endo; Archana Bora; Nidal Muvarak; Philip W Zoltick; Alan W Flake; Timothy R Brazelton
Journal:  Mol Ther       Date:  2010-06-22       Impact factor: 11.454

Review 6.  What can rodent models tell us about cognitive decline in Alzheimer's disease?

Authors:  Sabrina Davis; Serge Laroche
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

7.  Glial cell aquaporin-4 overexpression in transgenic mice accelerates cytotoxic brain swelling.

Authors:  Baoxue Yang; Zsolt Zador; A S Verkman
Journal:  J Biol Chem       Date:  2008-03-28       Impact factor: 5.157

Review 8.  Alzheimer's disease pathology in APOE transgenic mouse models: The Who, What, When, Where, Why, and How.

Authors:  Cutler T Lewandowski; Juan Maldonado Weng; Mary Jo LaDu
Journal:  Neurobiol Dis       Date:  2020-02-20       Impact factor: 5.996

9.  Introducing Human APOE into Aβ Transgenic Mouse Models.

Authors:  Leon M Tai; Katherine L Youmans; Lisa Jungbauer; Chunjiang Yu; Mary Jo Ladu
Journal:  Int J Alzheimers Dis       Date:  2011-10-19

10.  Identification of a Nuclear Respiratory Factor 1 Recognition Motif in the Apolipoprotein E Variant APOE4 linked to Alzheimer's Disease.

Authors:  Anne Urfer-Buchwalder; Roman Urfer
Journal:  Sci Rep       Date:  2017-01-17       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.